Close Menu

This piece gets in on big-money merit. Check out the Wall Street Journal for a quick story about Novartis and MorphoSys, a German biotech, expanding their collaboration -- to the tune of a 10-year, $600 million partnership. The alliance is geared toward "the discovery and development of antibody-based biological drugs," according to the article.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.